← Back to Search

Prehabilitation regimen for Pancreatic Resection

Waitlist Available
Led By Matthew Walsh, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing pancreatic resection over a six-month enrollment
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will help determine if making patients stronger through prehabilitation prior to surgery can improve surgical outcomes.

Eligible Conditions
  • Pancreatic Resection
  • Frailty

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in grip strength
Change in number of chair stands in 30 seconds (chair stand test)
Change in vitals and distance walked via 6-minute walk test
Secondary outcome measures
Energy expenditure
Heart rate
Number of chair sit stands performed
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: At-home prehabilitation regimenExperimental Treatment1 Intervention
Grip strength: Squeeze a stress ball in your hand, holding it squeezed for 5 seconds. Perform this at least thirty times with each hand over the course of a day. Lower body strength: Perform at least one hundred chair sit-stands in a day. Endurance: Walking at least 7,500 steps in a day.
First Studied
Drug Approval Stage
How many patients have taken this drug
Prehabilitation regimen

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
448 Previous Clinical Trials
31,345 Total Patients Enrolled
Matthew Walsh, MDPrincipal InvestigatorCleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the projected results of this experiment?

"The primary measure of success in this 4-week clinical trial is the change in grip strength. Secondary outcome metrics include number of chair sit stands, steps taken, and caloric expenditure as tracked by a supplied fitness device (Garmin Vivofit 4)."

Answered by AI

Is enrollment open right now for this clinical research?

"That is correct. Per the information on clinicaltrials.gov, this trial remains open for enrollment and was initially posted in March 2019 before being revised more recently in October 2022. 40 participants are needed from one medical centre."

Answered by AI
~7 spots leftby Apr 2025